MedTrace Logo

PS128 May Improve Off Duration on Parkinson's Disease

NCT04389762 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2025-08-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate the short term effects (12 Weeks) of Lactobacillus plantarum PS128 (PS128) on Parkinson's disease (PD) symptoms.

Conditions

  • Parkinson Disease

Interventions

DIETARY_SUPPLEMENT

daily ingestion of Lactobacillus plantarum PS128

daily ingestion of 60 billion colony forming unit (CFU) of Lactobacillus plantarum PS128 (30 billion CFU/capsule)

Sponsors & Collaborators

  • Professor Lu Neurological Clinic

    lead OTHER

Principal Investigators

  • Chin-Song Lu, MD · Professor Lu Neurological Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-04
Primary Completion
2020-05-13
Completion
2020-06-13

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04389762 on ClinicalTrials.gov